Mosaic ImmunoEngineering, Inc. is a development-stage biotechnology company focused on advancing and eventually commercializing immunotherapies for the treatment of cancer. The Company is focused on new product candidates and platforms to expand its pipeline based on a deep understanding of immunotherapies and its license agreements with University of California San Diego.
Back to dashboard
Company Information
About this company
Key people
Steven King
President, Chief Executive Officer, Director
Paul Lytle
Chief Financial Officer, Executive Vice President, Corporate Secretary, Director
Robert Baffi
Independent Director
Robert Garnick
Independent Director
Click to see more
Key facts
- Shares in issue7.24m
- EPICCPMV
- ISINUS61945M1018
- LocationUnited States
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap$441,770.00
- Employees2
- ExchangeOver The Counter
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.